-
2024 CSCO Guideline Symposium: Professor Tiejun Gong: “Updates to the CSCO Guidelines for Malignant Hematologic Diseases” Drive Clinical Diagnosis
With the development of targeted therapy and immunotherapy, the treatment options for malignant hematologic diseases continue to expand. The “Chinese Society of Clinical Oncology (CSCO) Guidelines for the Diagnosis and Treatment of Malignant Hematologic Diseases (2024)” has once again been updated. “Oncology Watch” specially interviewed one of the guideline’s authors, Professor Tiejun Gong from the…
-
Professor Qing Cao’s Commentary: Emerging Staphylococcus Threatens Newborn Health | ESCMID Global 2024
In low- and middle-income countries, the health of newborns faces numerous challenges, with neonatal sepsis being a particularly grave concern. At the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024), a study (abstract number: O0158) focused on the threat posed by Coagulase-Negative Staphylococci (CoNS) to newborn health. These bacteria, increasingly reported…
-
EBMT Distinguished Interview | Optimizing Induction Therapy Before ASCT: From Past to Future
Induction therapies with high remission rates, combined with high-dose chemotherapy and autologous stem cell transplantation (ASCT), have significantly improved the prognosis for multiple myeloma (MM) patients. Despite this, patients still inevitably experience disease progression or relapse. One of the key goals in this research field is how to maintain remission in patients after induction therapy…
-
Professor Wei Yu Shares Research Progress in NMIBC Treatment | EAU24 Expert Commentary
Transurethral resection of bladder tumors (TURBt) is the conventional treatment for non-muscle-invasive bladder cancer (NMIBC). Patients are stratified into low, intermediate, high, and very high risk categories, with different postoperative bladder instillation treatments and follow-up monitoring strategies for different risk patients. Several advancements in NMIBC research were presented at the recent EAU conference, and “Oncology…
-
Recent Advances in the Treatment of Advanced Urothelial Carcinoma: Insights from Dr. Jens Bedke
Platinum-based combination chemotherapy remains the cornerstone of treatment for advanced urothelial carcinoma (UC), but it still falls short of meeting long-term survival needs. At the 39th Annual Congress of the European Association of Urology (EAU24) held in Paris, France, Dr. Jens Bedke, from Klinikum Stuttgart Katharinen Hospital, shared the results of the EV-302/KEYNOTE-A39 study. Urology…
-
Professor Vasileios Sakalis on the Value of Artificial Intelligence in the Diagnosis and Treatment of Urological Tumors
Artificial Intelligence (AI) is transforming the diagnostic and treatment approaches for urological tumors, especially with significant advancements in intelligent imaging and pathology, potentially becoming an indispensable tool for clinicians. Dr. Vasileios Sakalis, a urologist from the Hippokrateion General Hospital of Thessaloniki, Greece, presented a comprehensive review on the application of AI in urological tumors at…
-
2024 CUDA Yanqi Lake Conference | Professor Xiongjun Ye Shares Recent Breakthroughs in Renal Cell Carcinoma Treatment
The ASCO-GU, a premier academic conference in urologic oncology, at the beginning of the year sparked academic enthusiasm in 2024, receiving over 140 abstracts related to renal cell carcinoma (RCC). Professor Xiongjun Ye from the Chinese Academy of Medical Sciences Cancer Hospital presented a report on the significant progress in RCC treatment from the ASCO-GU…
-
2024CUDA Conference | Professor Benkang Shi: Focus on Unmet Needs of mHSPC Patients, Achieve Stratified Treatment for Key Populations
The current treatment status of mHSPC patients in China and the need for further improvement have drawn attention. Recently, at the “4th Annual Conference of the Urology Physicians Branch of the Chinese Medical Association (2024)” held in Beijing, Professor Benkang Shi from Qilu Hospital of Shandong University shared insights on “Long-term Management of mHSPC Patients…
Connecting Medical Expertise through Media